Show notes
GERD 8: pH Monitoring, Impedance, and Diagnosing Refractory GERDEpisode keywords: ambulatory pH monitoring GERD, wireless Bravo pH capsule, impedance pH monitoring MII-pH, symptom index reflux, symptom association probability SAP, on versus off PPI pH testing, reflux hypersensitivity diagnosis, acid exposure time normal values, combined impedance pH refractory GERDEpisode SummaryThe decision to test on or off PPIs is the most important single judgment call in reflux monitoring, and it follows directly from one question: has GERD been objectively confirmed before? This episode covers the three monitoring platforms (catheter pH, wireless Bravo, combined impedance-pH), the specific clinical scenarios that call for each, the on-versus-off PPI algorithm, and the SI and SAP metrics including their well-documented limitations.Key TopicsIndications for ambulatory reflux monitoring: Two broad scenarios. First, heartburn persisting despite optimized PPI therapy where objective characterization is needed. Second, GERD diagnosis has never been objectively established and empiric PPI therapy is being questioned. Atypical presentations (chest pain without heartburn, isolated cough, laryngeal symptoms) also warrant testing when typical GERD symptoms are absent.Catheter pH monitoring: pH electrode placed transnasally, positioned 5 cm above the LES, records 24 hours. Measures acid exposure time (percentage of recording period with pH below 4). Abnormal above 6%. Normal below 4%. Indeterminate (grey zone) between 4 and 6%. Foundation platform for reflux diagnosis.Wireless Bravo pH monitoring: Capsule clipped to esophageal mucosa during endoscopy, transmits pH wirelessly. Records 48 to 96 hours versus 24, improving diagnostic yield because day-to-day reflux variability is captured. Better patient tolerance means more representative activity patterns. Limitation: measures acid only, no impedance capability.Combined impedance-pH monitoring (MII-pH): Nasal catheter with impedance sensors plus a pH electrode. Impedance principle: liquid has low electrical impedance (conducts electricity), air has high impedance. Retrograde liquid bolus produces a characteristic impedance drop propagating proximally. The pH electrode classifies each reflux event as acidic, weakly acidic, or non-acidic. Detects all reflux regardless of acidity -- critical for testing patients on PPI therapy, where acid is suppressed but reflux events still occur at pH-neutral values.The on-versus-off PPI decision: If GERD has NOT been objectively established (no prior positive pH study, no prior LA-C or D esophagitis, no documented Barrett's), test OFF PPIs after at least 7 days of discontinuation. The question is whether pathologic reflux exists at all. Testing on PPIs risks false-negative acid suppression. If GERD IS established (prior positive pH study, long-segment Barrett's, prior LA-C or D esophagitis), and symptoms persist on twice-daily PPI, test ON PPIs with combined impedance-pH. The question is why established GERD is not responding. Is there breakthrough acid? Non-acidic reflux with symptom correlation? Or no reflux-symptom association at all? Note: LA-A does not establish GERD. LA-B is borderline. Only LA-C and D represent confirmed erosive disease.Symptom Index (SI): Number of symptom episodes within a defined time window of a reflux event divided by total symptom episodes. SI above 50% is positive. Simple but does not account for the baseline probability of overlap when reflux events are very frequent.Symptom Association Probability (SAP): Divides the 24-hour recording into 720 two-minute intervals. Marks each for reflux occurrence and symptom report. Applies Fisher's exact test. SAP above 95% is positive. Statistically more sophisticated and adjusts for baseline co-occurrence probability.Limitations of both metrics: No study has demonstrated SAP provides better clinical information than SI in predicting treatment outcomes. They frequently disagree. Both depend on patients accurately pressing a symptom button in real time. Both use arbitrary time windows to define association. Neither has been validated as a strong predictor of antireflux therapy response. Boards expect you to know the formulas and cutoffs AND to know these limitations.RCT evidence for impedance-pH: A randomized controlled trial demonstrated that treatment decisions guided by impedance-pH results produced better outcomes than empiric management in PPI-refractory heartburn. This moved combined impedance-pH from research tool to evidence-based clinical recommendation for the on-PPI testing scenario.Board PearlsHigh-yield: The on-versus-off PPI pivot is a single question -- has GERD been objectively proven before? No prior proof: test off. Proven GERD with persistent symptoms: test on with impedance-pH.High-yield: LA-C and D esophagitis and long-segment Barrett's constitute established GERD. These patients do not need additional pH testing to confirm the diagnosis. LA-A does not confirm GERD.Board trap: SI and SAP frequently disagree, and neither has strong predictive validity for treatment response. Know the formulas and cutoffs but do not treat either metric as definitive in isolation.